Ocuphire Pharma, Inc. (OCUP) Earnings
|
Expand Research on OCUP
Next EPS Date | 5/3/24 | EPS Growth Rate | +67.9% |
---|---|---|---|
Average EPS % Beat Rate | -46.4% | Revenue Growth Rate | +230.9% |
Average % Move 1-Wk after EPS | -11.6% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/3/24 | Q124 | N/A | -$0.09 | N/A | N/A | $5.79M | N/A | N/A | N/A | ||
3/8/24 | Q423 | -$0.21 | -$0.05 | -$0.16 | $1.69M | $5.36M | N/A | Details | |||
11/10/23 | Q323 | N/A | -$0.22 | N/A | N/A | $3.03M | N/A | N/A | N/A | ||
11/13/23 | Q323 | $0.25 | -$0.22 | +$0.47 | $11.9M | $3.03M | N/A | Details | |||
8/11/23 | Q223 | -$0.24 | -$0.23 | -$0.01 | $3.67M | $2.43M | N/A | Details | |||
5/15/23 | Q123 | -$0.28 | -$0.16 | -$0.12 | $1.75M | $3.68M | N/A | Details | |||
3/8/23 | Q422 | N/A | $1.32 | N/A | N/A | $29.45M | N/A | N/A | N/A | ||
3/27/23 | Q422 | N/A | $1.32 | N/A | N/A | $29.45M | N/A | N/A | N/A |